On Monday a patient marks pain at seven out of ten. By Friday it is down to four. Three points of relief can mean the difference between finishing a meal with friends and leaving early. In a trial of a cannabis-based treatment, the same change raises a second question. How much improvement would have occurred over those days if the patient had been assigned to the comparison group?
A diary is a record of experience
Pain has no external meter that can replace a person’s report. A diary gives that report a schedule and a consistent scale. Asking about average pain over the day is slightly different from asking about pain right now, or about the worst pain since waking. Someone with a brief but intense flare might give three very different numbers to those questions. Researchers need to specify which one they plan to analyze.
The starting point matters as well. People seeking entry into a pain trial may be especially motivated during a difficult period. If symptoms naturally fluctuate, some will improve as an unusually bad week passes. Others may feel better because they receive attention, reassurance or help with aspects of their usual care. A change within a group combines all these possibilities with any effect of its assigned treatment.
Why the comparison group also gets a diary
Random assignment helps distribute influences other than treatment between the groups. If everyone completes the same diary on the same schedule, the difference between the groups’ changes becomes more informative than either change by itself. Suppose the treatment group improves three points and the placebo group two. The contrast attributable to assignment is closer to one point in this illustration, even though the average person in the treatment group experienced three points of improvement.
A meta-analysis of placebo responses in cannabis-based pain trials found substantial improvement among participants receiving placebo. That observation does not imply they imagined their pain or their relief. “Placebo response” in this setting describes the change observed in the comparison group. It bundles natural fluctuations, expectations, study participation and other influences that a two-group trial cannot individually separate.
An average hides the shape of the week
Two diaries can yield an identical average while telling different stories. One patient improves a little every day. Another returns to their usual pain for most of the week but enjoys a single exceptionally good afternoon. A researcher interested in sustained benefit might count days above a predefined threshold. A researcher interested in function might ask whether a participant can walk to the shops or sleep through the night. Neither question is answered by the arithmetic mean alone.
Reviews have to contend with variation in the treatments too. The AHRQ living review of cannabis and other plant-based treatments for chronic pain distinguishes preparations and outcomes. An estimate obtained with one formulation in people with a particular type of pain cannot simply be carried over to every cannabis product or every painful condition. Adverse effects and the length of follow-up belong beside estimates of relief.
When participants guess their assignment
THC can produce perceptible effects, which raises a further problem for blinding. If a participant guesses what they received, expectations may influence how they interpret an ambiguous change. Research on maintaining blinding in cannabinoid analgesia trials explains why the resemblance between active treatment and placebo is worth examining. A correct guess alone, however, cannot tell us whether the guess caused improvement or improvement prompted the guess.
A diary records something indispensable: how a person’s days felt. Randomization and a comparator supply the part the diary cannot know. The patient’s question about Friday and the trial’s question about causation both deserve answers. Confusion begins when three points of personal relief are presented as three points of benefit caused entirely by the treatment.